Akari Therapeutics Announces Appointment of David Horn Solomon as CEO
Aug 21, 2017 11:05 am UTC| Business
NEW YORK and LONDON, Aug. 21, 2017 -- Akari Therapeutics (NASDAQ:AKTX) is pleased to announce that Dr David Horn Solomon will be appointed as the company’s new chief executive officer (CEO), effective August 28, 2017. ...
RADA Raises $10M from Leading Israeli Institutional Investors
Aug 21, 2017 11:00 am UTC| Business
NETANYA, Israel, Aug. 21, 2017 -- RADA Electronic Industries Ltd. (NASDAQ:RADA) today announced that it has received and accepted purchase offers from several Israeli institutional investors to purchase 4,604,500...
Fortuna FLNG Offtake Awarded to Gunvor
Aug 21, 2017 11:00 am UTC| Business
MALABO, Equatorial Guinea, Aug. 21, 2017 -- The Ministry of Mines and Hydrocarbons (“MMH”), Ophir Equatorial Guinea (Block R) Ltd, OneLNG SA and La Compania Nacional De Petroleos De Guinea Ecuatorial (“GEPetrol”) have...
IGC Announces Financial Results for Quarter Ended June 30, 2017
Aug 21, 2017 11:00 am UTC| Business
BETHESDA, Md., Aug. 21, 2017 -- India Globalization Capital, Inc. (NYSE AMERICAN:IGC) announces financial results for the quarter ended June 30, 2017. “During the quarter, we secured an IP licensing agreement from the...
Recro Pharma Appoints Jyrki Mattila as Executive Vice President of Business Development
Aug 21, 2017 11:00 am UTC| Business
MALVERN, Pa., Aug. 21, 2017 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced the appointment...
Abattis Announces Receipt of Cultivation License by LP Partner
Aug 21, 2017 11:00 am UTC| Business
VANCOUVER, British Columbia, Aug. 21, 2017 -- Abattis Bioceuticals Corp. (the ”Company“ or ”Abattis“) (CSE:ATT) (OTC:ATTBF) and its majority-owned testing and laboratory subsidiary, Northern Vine Canada Inc. (“Northern...
BeyondSpring Provides Operational Update for Second Quarter of 2017
Aug 21, 2017 11:00 am UTC| Business
NEW YORK, Aug. 21, 2017 -- BeyondSpring Inc. (NASDAQ:BYSI) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development of a pipeline of innovative immuno-oncology...